Skip to main content
. Author manuscript; available in PMC: 2021 Feb 4.
Published in final edited form as: J Am Coll Cardiol. 2020 Feb 18;75(6):620–628. doi: 10.1016/j.jacc.2019.11.059

TABLE 2.

Types of CVD Events Reported

Type of CVD Reported* Trials
Heart failure 30 (15.9)
ACS 13 (6.9)
Atrial fibrillation 9 (4.8)
Uncontrolled HTN 30 (15.9)
Thromboembolic disease 34 (18.0)
CVA 26 (13.8)
Coronary revascularization§ 1 (0.5)
Myocarditis 0 (0.0)
Cardiovascular death|| 56 (29.6)
Other CVD 17 (9.0)
Multiple CVD events# 39 (20.6)

Values are n (%).

*

The sum of the trial excluded is >100% and greater than the overall number of excluded trials because several studies used multiple exclusion criteria.

The percentages reported reflect a denominator of 189.

Usually defined as >150/90 mm Hg, consistent with mild (i.e., stage 1) hypertension by the available contemporary guidelines.

§

No trials reported peripheral revascularizations.

||

Includes those with sudden cardiac death or coronary artery disease–related death or any other mention of cardiovascular death.

Other CVD included valvular disease, myocarditis, or other mention of cardiovascular disease

#

Trials where multiple types of CVD events (e.g., ACS, and heart failure) were reported. ACS = acute coronary syndrome; CVA = cerebrovascular accident;

ACS = acute coronary syndrome; CVA = cerebrovascular accident; CVD = cardiovascular disease; HTN = hypertension.